Form 4: Avidity Biosciences Director Arthur Levin Sells 20,000 Shares

Director Arthur Levin sold 20,000 shares of Avidity Biosciences (RNA) at an average price of $27.1107 on April 3, 2024.

Summary

• On April 3, 2024, Arthur Levin, a director of Avidity Biosciences, Inc. (RNA), sold 20,000 shares of common stock.
• The sale was executed at a weighted-average price of $27.1107 per share, with individual transactions ranging from $27.00 to $27.28.
• Following the transaction, Levin directly owns 14,830 shares and indirectly owns 253,872 shares through a family trust.
• The directly owned shares include 13,500 RSUs under the Issuer's 2020 Incentive Award Plan and 1,330 shares of common stock under the Issuer's 2020 Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of stock sale. The sale itself doesn't necessarily indicate a positive or negative outlook.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company insiders, allowing investors to monitor potential shifts in sentiment or alignment with company performance.

Stakeholder Impact

• The stock sale by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the sale relative to the director's total holdings.

Key Dates